Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosis

被引:12
作者
Burger, David M. [1 ,2 ]
Magis-Escurra, Cecile [3 ]
van den Berk, Guido E. L. [4 ]
Gelinck, Luc B. S. [5 ]
机构
[1] Radboud Univ Nijmegen, Dept Clin Pharm, Med Ctr, Nijmegen, Netherlands
[2] Nijmegen Inst Infect Inflammat & Immunol N4I, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Dept Lung Dis, Med Ctr, Nijmegen, Netherlands
[4] OLVG, Dept Internal Med, Amsterdam, Netherlands
[5] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands
关键词
HEALTHY-VOLUNTEERS; INTEGRASE; RITONAVIR; INHIBITOR; RIFAMPIN;
D O I
10.1097/QAD.0b013e3283350f08
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:328 / 330
页数:3
相关论文
共 14 条
[1]   Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects [J].
Anderson, Matt S. ;
Kakuda, Thomas N. ;
Hanley, William ;
Miller, Jutta ;
Kost, James T. ;
Stoltz, Randall ;
Wenning, Larissa A. ;
Stone, Julie A. ;
Hoetelmans, Richard M. W. ;
Wagner, John A. ;
Iwamoto, Marian .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (12) :4228-4232
[2]  
Centers for Disease Control and Prevention, MAN DRUG INT TREATM
[3]  
*EMEA, 2009, IS SUMM PROD CHAR VE
[4]  
FDA, 2009, IS PRESCR INF VERS J
[5]   Raltegravir treatment response in an HIV-2 infected patient: a case report [J].
Garrett, Nigel ;
Xu, Li ;
Smit, Erasmus ;
Ferns, Bridget ;
El-Gadi, Saleh ;
Anderson, Jane .
AIDS, 2008, 22 (09) :1091-1092
[6]   Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and Ritonavir [J].
Haas, David W. ;
Koletar, Susan L. ;
Laughlin, Laura ;
Kendall, Michelle A. ;
Suckow, Carol ;
Gerber, John G. ;
Zolopa, Andrew R. ;
Bertz, Richard ;
Child, Michael J. ;
Hosey, Lara ;
Alston-Smith, Beverly ;
Acosta, Edward P. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (03) :290-293
[7]   Effect of Tipranavir-Ritonavir on Pharmacokinetics of Raltegravir [J].
Hanley, William D. ;
Wenning, Larissa A. ;
Moreau, Allison ;
Kost, James T. ;
Mangin, Eric ;
Shamp, Trisha ;
Stone, Julie A. ;
Gottesdiener, Keith M. ;
Wagner, John A. ;
Iwamoto, Marian .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (07) :2752-2755
[8]   Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir [J].
Iwamoto, Marian ;
Wenning, Larissa A. ;
Petry, Amelia S. ;
Laethem, Martine ;
De Smet, Marina ;
Kost, James T. ;
Breidinger, Sheila A. ;
Mangin, Eric C. ;
Azrolan, Neal ;
Greenberg, Howard E. ;
Haazen, Wouter ;
Stone, Julie A. ;
Gottesdiener, Keith M. ;
Wagner, John A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (12) :4338-4343
[9]   Rifamycin-Resistant Mycobacterium tuberculosis in the Highly Active Antiretroviral Therapy Era: A Report of 3 Relapses with Acquired Rifampin Resistance following Alternate-Day Rifabutin and Boosted Protease Inhibitor Therapy [J].
Jenny-Avital, Elizabeth R. ;
Joseph, Kareen .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (10) :1471-1474
[10]   Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals [J].
Markowitz, Martin ;
Morales-Ramirez, Javier O. ;
Nguyen, Bach-Yen ;
Kovacs, Colin M. ;
Steigbigel, Roy T. ;
Cooper, David A. ;
Liporace, Ralph ;
Schwartz, Robert ;
Isaacs, Robin ;
Gilde, Lucinda R. ;
Penning, Larissa ;
Zhao, Jing ;
Teppler, Hedy .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (05) :509-515